Article Information
History
- February 10, 2022.
Article Versions
- Version 1 (January 21, 2022 - 22:54).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- S. Vangeti1,
- S. Falck-Jones1,
- M. Yu1,
- B. Österberg1,
- S. Liu1,
- M. Asghar2,3,
- K. Sondén2,3,
- J. Albert4,5,
- N. Johansson2,3,
- A. Färnert2,3 and
- A. Smed-Sörensen1,*
- 1Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 2Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Sweden
- 3Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- 4Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
- 5Department of Clinical Microbiology, Karolinska University Hospital, Stockholm, Sweden
- ↵*Correspondence to: Dr. Anna Smed-Sörensen, Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, NKS BioClinicum J7:30, Visionsgatan 4, 171 64 Stockholm, Sweden. Phone: +46 73 712 1641. E-mail: anna.smed.sorensen{at}ki.se.